Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”
| dc.contributor.author | Phillips, Richard Odame | |
| dc.contributor.author | Sarfo, Fred Stephen | |
| dc.contributor.author | Abass, Mohammed K. | |
| dc.contributor.author | Frimpong, Michael | |
| dc.contributor.author | Ampadu, Edwin | |
| dc.contributor.author | et. al | |
| dc.date.accessioned | 2020-01-13T12:51:46Z | |
| dc.date.accessioned | 2023-04-19T01:48:00Z | |
| dc.date.available | 2020-01-13T12:51:46Z | |
| dc.date.available | 2023-04-19T01:48:00Z | |
| dc.date.issued | 2014-10 | |
| dc.description | An article published by Antimicrobial Agents and Chemotherapy and available at doi:10.1128/AAC.03874-14 | en_US |
| dc.description.abstract | Recently, Klis et al. conducted an audit of Buruli ulcer case record forms of patients managed under routine care conditions in a Buruli ulcer treatment center and showed a surprisingly high rate (54%) of noncompliance with therapy (1). Incomplete adherence to treatment has been identified as the most serious problem in tuberculosis control (2) and a major obstacle to the elimination of the disease (3). To ensure adherence to therapy in our study, several approaches were incorporated into patient care. These included issuing medication in 2-weekly batches, allowing the clinician several opportunities to assess adherence during therapy. | en_US |
| dc.description.sponsorship | KNUST | en_US |
| dc.identifier.citation | Antimicrobial Agents and Chemotherapy Volume 58 Number 10 | en_US |
| dc.identifier.uri | https://ir.knust.edu.gh/handle/123456789/11922 | |
| dc.language.iso | en | en_US |
| dc.publisher | Antimicrobial Agents and Chemotherapy | en_US |
| dc.title | Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer” | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”.pdf
- Size:
- 80.46 KB
- Format:
- Adobe Portable Document Format
- Description: